Analysts' ratings for Alcon (NYSE: ALC) over the last quarter vary from bullish to bearish, as provided by 10 analysts. In the table below, you'll find a summary of their recent ratings, revealing the ...

Alcon’s ALC Vision Care business continues to gain from its diverse portfolio of contact lenses and ocular health products. Additionally, growth momentum within the Surgical business is poised to ...

†Compared to CENTURION and CONSTELLATION Vision Systems. Based on bench data. **Based on worldwide unit sales of AcrySof ® IQ Vivity and Clareon Vivity IOLs, as of Q4, 2024. “As ophthalmic practices ...

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will present compelling scientific data at the 43 rd ...

Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "North America Intraocular Lens Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets ...

Cutting-edge technologies UNITY VCS, Clareon Vivity, Voyager DSLT, now commercially available in Europe, to be featured at Alcon booth and throughout conference activities New data on Vivity IOLs ...

(MENAFN- GlobeNewsWire - Nasdaq) The North America Intraocular Lens Market is projected to grow from US$ 1.53 billion in 2024 to US$ 2.38 billion by 2033, achieving a CAGR of 5.00% from 2025 to 2033.

Alcon Inc. upgraded to buy: discover why eyecare demand, strong cashflow, and growth potential could drive shares up 35%.

Alcon, which set up in West Virginia in 1989, also expanded its operations in Cabell County with a $45-million investment ...